Archive: 09/02/2023
AstraZeneca profits soar on cancer drugs, Alexion buy
Anglo-Swedish drugmaker AstraZeneca on Thursday posted surging annual net profit, boosted by cancer treatments and the integration of biotech unit Alexion following a blockbuster takeover.
Feb 9, 2023